SATURDAY 3 OCT
14:20 – 15:00
Using AI to optimise deep shotgun metagenomic sequencing, microbiome-specific
About the session
The gut microbiome contains extraordinary biological information. However, translating a stool sample into clinically useful insight has remained difficult. In this talk, healthcare AI pioneer and Jona founder Leo Grady, PhD, explores how deep shotgun metagenomic sequencing, microbiome-specific AI and new digital-twin technology can provide a comprehensive analysis of your health though the gut microbiome and make this information actionable.
Drawing on Jona’s research and clinical examples, Leo will show how AI connects an individual’s microbiome with the rapidly expanding scientific literature and simulates how diet, lifestyle, supplements, probiotics and medications may alter it. He will examine applications in early colorectal cancer risk, gastrointestinal symptoms and metabolic disease, while addressing the field’s limitations and unanswered questions. Attendees will leave with a practical view of where microbiome testing can support prevention and patient management today, and how to use it as evidence-linked decision support without confusing association with diagnosis.
Speaker
Leo GradyDr.
Leo is the Founder and CEO of Jona, a health technology company that developed AI to comprehensively analyze the gut microbiome and to simulate the effect of different interventions on the gut in order to unlock the utility of the gut microbiome and significantly improve health. He is internationally recognized for his two decades of leadership in applying AI to healthcare, including leadership roles at pioneering Bay Area AI startups (HeartFlow), multinational medical companies (Siemens) and as CEO of Paige.ai. At Paige.ai, he led the company to become an industry leader, launching groundbreaking products globally and securing the first-ever FDA approval for an AI product in pathology. Leo has authored two books on AI, published over 100 peer-reviewed scientific papers and is an inventor on more than 300 patents. A recipient of the Edison Patent Award, he was inducted as a Fellow of the American Institute for Medical and Biological Engineering. He earned his Ph.D. in Cognitive and Neural Systems from Boston University and serves as CEO in Residence at Breyer Capital.
Your host on the Precision Stage
STAGE HOSTDr. Julie MolkeMedical Doctor
Dr. Julie Moltke is a Copenhagen‑based physician, health advocate, author and peer‑reviewed researcher specialising in prevention, personalised medicine, longevity, hormonal health and mental health.
She delivers evidence‑based, individualised care using advanced diagnostics, lifestyle medicine and targeted therapies to reduce disease risk and strengthen long‑term resilience.
Øksnehallen, Halmtorvet 11, 1700 Copenhagen · All sessions are first come, first served.
SEE FULL PROGRAM